General Intermediates of Canada, an Alberta Biotech Company, Receives Canadian Government Funding for Immuno-Oncology Project
Edmonton, Alberta (ots/PRNewswire) - Edmonton's GIC in pursuit of new immuno-oncology therapy Edmonton's General Intermediates of Canada Inc. (GIC) announced today that they have received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related to ...
mehr